Lam Research shares downgraded on weak 2026 outlook

Morgan Stanley downgraded Lam Research Co. to underweight with a $92 price target, approximately 10% below current levels, anticipating the chip-equipment maker's recent outperformance will not extend into 2026. The brokerage expects growth drivers to fade, projecting Lam's 2026 shipment growth to normalize to around 5% in line with the broader market, as cooling NAND demand and slowing China sales—which comprise over half of Lam's shipments—weigh on results. Despite 2026 forecasts slightly above consensus, Morgan Stanley suggests investor expectations are already elevated, limiting share price upside and positioning Lam to lag larger US semiconductor equipment peers as growth normalizes.

Analysis

Morgan Stanley has downgraded Lam Research (LRCX) to underweight, issuing a $92 price target that represents approximately 10% downside from current levels. The rationale for the downgrade is the view that Lam's recent outperformance, driven by market share gains from NAND customers and strong sales to China, is unlikely to continue into 2026. The bank forecasts Lam's shipment growth will decelerate to about 5% in 2026, aligning with the broader wafer fabrication equipment market after outpacing it in 2024 and 2025. This anticipated slowdown is linked to cooling NAND demand and moderating growth in China, which together constitute over half of Lam's shipments. A key insight from the analysis is that even though Morgan Stanley's 2026 forecasts are slightly above consensus, investor expectations may already be significantly higher, thus capping share price upside. This sentiment is supported by the stock's price decline following an above-estimate September-quarter sales guidance, suggesting the market had priced in even stronger results. The $92 price target is based on an 18-times multiple on 2026 earnings—a premium to the company's long-term average—yet still implies Lam will lag its larger US semiconductor equipment peers as growth normalizes.

Key Decisions for Investors

• Investors should consider that Lam Research's strong outlook may already be fully priced into the stock, increasing the risk of downside on any failure to exceed already elevated market expectations.
• Monitor leading indicators for the NAND market and Chinese semiconductor capital spending, as these two drivers comprise over 50% of shipments and are central to the bearish thesis of normalizing growth in 2026.
• It may be prudent to re-evaluate positions in LRCX relative to larger US semiconductor equipment peers, which are projected to offer better relative performance as Lam's growth normalizes to the market average.
• Watch for counter-signals that could invalidate the downgrade, such as stronger-than-expected sales in China or accelerated adoption of advanced chips at Taiwan Semiconductor Manufacturing Co.